Search

Your search keyword '"Boucot, Isabelle H"' showing total 10 results
Start Over Author "Boucot, Isabelle H" Topic fos: health sciences
10 results on '"Boucot, Isabelle H"'

1. Supplementary_Figures_and_Table – Supplemental material for Impact of baseline COPD symptom severity on the benefit from dual versus mono-bronchodilators: an analysis of the EMAX randomised controlled trial

Author

Vogelmeier, Claus F., Kerwin, Edward M., Bjermer, Leif H., Tombs, Lee, Jones, Paul W., Boucot, Isabelle H., Naya, Ian P., Lipson, David A., Compton, Chris, Barnes, Neil, and Maltais, François

Subjects
110203 Respiratory Diseases, FOS: Clinical medicine, 111702 Aged Health Care, FOS: Health sciences, 111599 Pharmacology and Pharmaceutical Sciences not elsewhere classified
Abstract

Supplemental material, Supplementary_Figures_and_Table for Impact of baseline COPD symptom severity on the benefit from dual versus mono-bronchodilators: an analysis of the EMAX randomised controlled trial by Claus F. Vogelmeier, Edward M. Kerwin, Leif H. Bjermer, Lee Tombs, Paul W. Jones, Isabelle H. Boucot, Ian P. Naya, David A. Lipson, Chris Compton, Neil Barnes and François Maltais in Therapeutic Advances in Respiratory Disease

Published
2020
Full Text
View/download PDF

2. Reviewer_1_v.1 – Supplemental material for Early and sustained symptom improvement with umeclidinium/vilanterol versus monotherapy in COPD: a post hoc analysis of the EMAX randomised controlled trial

Author

Kerwin, Edward M, Boucot, Isabelle H, Vogelmeier, Claus F, Francois Maltais, Naya, Ian P, Tombs, Lee, Jones, Paul W, Lipson, David A, Keeley, Tom, and Bjermer, Leif

Subjects
110203 Respiratory Diseases, FOS: Clinical medicine, 111702 Aged Health Care, FOS: Health sciences, 111599 Pharmacology and Pharmaceutical Sciences not elsewhere classified
Abstract

Supplemental material, Reviewer_1_v.1 for Early and sustained symptom improvement with umeclidinium/vilanterol versus monotherapy in COPD: a post hoc analysis of the EMAX randomised controlled trial by Edward M Kerwin, Isabelle H Boucot, Claus F Vogelmeier, Francois Maltais, Ian P Naya, Lee Tombs, Paul W Jones, David A Lipson, Tom Keeley and Leif Bjermer in Therapeutic Advances in Respiratory Disease

Published
2020
Full Text
View/download PDF

3. Supp_Figure_2_HR – Supplemental material for Early and sustained symptom improvement with umeclidinium/vilanterol versus monotherapy in COPD: a post hoc analysis of the EMAX randomised controlled trial

Author

Kerwin, Edward M, Boucot, Isabelle H, Vogelmeier, Claus F, Francois Maltais, Naya, Ian P, Tombs, Lee, Jones, Paul W, Lipson, David A, Keeley, Tom, and Bjermer, Leif

Subjects
110203 Respiratory Diseases, FOS: Clinical medicine, 111702 Aged Health Care, FOS: Health sciences, 111599 Pharmacology and Pharmaceutical Sciences not elsewhere classified
Abstract

Supplemental material, Supp_Figure_2_HR for Early and sustained symptom improvement with umeclidinium/vilanterol versus monotherapy in COPD: a post hoc analysis of the EMAX randomised controlled trial by Edward M Kerwin, Isabelle H Boucot, Claus F Vogelmeier, Francois Maltais, Ian P Naya, Lee Tombs, Paul W Jones, David A Lipson, Tom Keeley and Leif Bjermer in Therapeutic Advances in Respiratory Disease

Published
2020
Full Text
View/download PDF

4. Supp_Figure_1_HR – Supplemental material for Early and sustained symptom improvement with umeclidinium/vilanterol versus monotherapy in COPD: a post hoc analysis of the EMAX randomised controlled trial

Author

Kerwin, Edward M, Boucot, Isabelle H, Vogelmeier, Claus F, Francois Maltais, Naya, Ian P, Tombs, Lee, Jones, Paul W, Lipson, David A, Keeley, Tom, and Bjermer, Leif

Subjects
110203 Respiratory Diseases, FOS: Clinical medicine, 111702 Aged Health Care, FOS: Health sciences, 111599 Pharmacology and Pharmaceutical Sciences not elsewhere classified
Abstract

Supplemental material, Supp_Figure_1_HR for Early and sustained symptom improvement with umeclidinium/vilanterol versus monotherapy in COPD: a post hoc analysis of the EMAX randomised controlled trial by Edward M Kerwin, Isabelle H Boucot, Claus F Vogelmeier, Francois Maltais, Ian P Naya, Lee Tombs, Paul W Jones, David A Lipson, Tom Keeley and Leif Bjermer in Therapeutic Advances in Respiratory Disease

Published
2020
Full Text
View/download PDF

5. Author_Response – Supplemental material for Early and sustained symptom improvement with umeclidinium/vilanterol versus monotherapy in COPD: a post hoc analysis of the EMAX randomised controlled trial

Author

Kerwin, Edward M, Boucot, Isabelle H, Vogelmeier, Claus F, Francois Maltais, Naya, Ian P, Tombs, Lee, Jones, Paul W, Lipson, David A, Keeley, Tom, and Bjermer, Leif

Subjects
110203 Respiratory Diseases, FOS: Clinical medicine, 111702 Aged Health Care, FOS: Health sciences, 111599 Pharmacology and Pharmaceutical Sciences not elsewhere classified
Abstract

Supplemental material, Author_Response for Early and sustained symptom improvement with umeclidinium/vilanterol versus monotherapy in COPD: a post hoc analysis of the EMAX randomised controlled trial by Edward M Kerwin, Isabelle H Boucot, Claus F Vogelmeier, Francois Maltais, Ian P Naya, Lee Tombs, Paul W Jones, David A Lipson, Tom Keeley and Leif Bjermer in Therapeutic Advances in Respiratory Disease

Published
2020
Full Text
View/download PDF

6. Reviewer_1_v.1 – Supplemental material for Impact of baseline COPD symptom severity on the benefit from dual versus mono-bronchodilators: an analysis of the EMAX randomised controlled trial

Author

Vogelmeier, Claus F., Kerwin, Edward M., Bjermer, Leif H., Tombs, Lee, Jones, Paul W., Boucot, Isabelle H., Naya, Ian P., Lipson, David A., Compton, Chris, Barnes, Neil, and Maltais, François

Subjects
110203 Respiratory Diseases, FOS: Clinical medicine, 111702 Aged Health Care, FOS: Health sciences, 111599 Pharmacology and Pharmaceutical Sciences not elsewhere classified
Abstract

Supplemental material, Reviewer_1_v.1 for Impact of baseline COPD symptom severity on the benefit from dual versus mono-bronchodilators: an analysis of the EMAX randomised controlled trial by Claus F. Vogelmeier, Edward M. Kerwin, Leif H. Bjermer, Lee Tombs, Paul W. Jones, Isabelle H. Boucot, Ian P. Naya, David A. Lipson, Chris Compton, Neil Barnes and François Maltais in Therapeutic Advances in Respiratory Disease

Published
2020
Full Text
View/download PDF

7. Reviewer_2_v.1 – Supplemental material for Impact of baseline COPD symptom severity on the benefit from dual versus mono-bronchodilators: an analysis of the EMAX randomised controlled trial

Author

Vogelmeier, Claus F., Kerwin, Edward M., Bjermer, Leif H., Tombs, Lee, Jones, Paul W., Boucot, Isabelle H., Naya, Ian P., Lipson, David A., Compton, Chris, Barnes, Neil, and Maltais, François

Subjects
110203 Respiratory Diseases, FOS: Clinical medicine, 111702 Aged Health Care, FOS: Health sciences, 111599 Pharmacology and Pharmaceutical Sciences not elsewhere classified
Abstract

Supplemental material, Reviewer_2_v.1 for Impact of baseline COPD symptom severity on the benefit from dual versus mono-bronchodilators: an analysis of the EMAX randomised controlled trial by Claus F. Vogelmeier, Edward M. Kerwin, Leif H. Bjermer, Lee Tombs, Paul W. Jones, Isabelle H. Boucot, Ian P. Naya, David A. Lipson, Chris Compton, Neil Barnes and François Maltais in Therapeutic Advances in Respiratory Disease

Published
2020
Full Text
View/download PDF

8. Supplementary_data – Supplemental material for Early and sustained symptom improvement with umeclidinium/vilanterol versus monotherapy in COPD: a post hoc analysis of the EMAX randomised controlled trial

Author

Kerwin, Edward M, Boucot, Isabelle H, Vogelmeier, Claus F, Francois Maltais, Naya, Ian P, Tombs, Lee, Jones, Paul W, Lipson, David A, Keeley, Tom, and Bjermer, Leif

Subjects
110203 Respiratory Diseases, FOS: Clinical medicine, 111702 Aged Health Care, FOS: Health sciences, 111599 Pharmacology and Pharmaceutical Sciences not elsewhere classified
Abstract

Supplemental material, Supplementary_data for Early and sustained symptom improvement with umeclidinium/vilanterol versus monotherapy in COPD: a post hoc analysis of the EMAX randomised controlled trial by Edward M Kerwin, Isabelle H Boucot, Claus F Vogelmeier, Francois Maltais, Ian P Naya, Lee Tombs, Paul W Jones, David A Lipson, Tom Keeley and Leif Bjermer in Therapeutic Advances in Respiratory Disease

Published
2020
Full Text
View/download PDF

9. Author_Response_1 – Supplemental material for Impact of baseline COPD symptom severity on the benefit from dual versus mono-bronchodilators: an analysis of the EMAX randomised controlled trial

Author

Vogelmeier, Claus F., Kerwin, Edward M., Bjermer, Leif H., Tombs, Lee, Jones, Paul W., Boucot, Isabelle H., Naya, Ian P., Lipson, David A., Compton, Chris, Barnes, Neil, and Maltais, François

Subjects
110203 Respiratory Diseases, FOS: Clinical medicine, 111702 Aged Health Care, FOS: Health sciences, 111599 Pharmacology and Pharmaceutical Sciences not elsewhere classified
Abstract

Supplemental material, Author_Response_1 for Impact of baseline COPD symptom severity on the benefit from dual versus mono-bronchodilators: an analysis of the EMAX randomised controlled trial by Claus F. Vogelmeier, Edward M. Kerwin, Leif H. Bjermer, Lee Tombs, Paul W. Jones, Isabelle H. Boucot, Ian P. Naya, David A. Lipson, Chris Compton, Neil Barnes and François Maltais in Therapeutic Advances in Respiratory Disease

Published
2020
Full Text
View/download PDF

10. Reviewer_2_v.1 – Supplemental material for Early and sustained symptom improvement with umeclidinium/vilanterol versus monotherapy in COPD: a post hoc analysis of the EMAX randomised controlled trial

Author

Kerwin, Edward M, Boucot, Isabelle H, Vogelmeier, Claus F, Francois Maltais, Naya, Ian P, Tombs, Lee, Jones, Paul W, Lipson, David A, Keeley, Tom, and Bjermer, Leif

Subjects
110203 Respiratory Diseases, FOS: Clinical medicine, 111702 Aged Health Care, FOS: Health sciences, 111599 Pharmacology and Pharmaceutical Sciences not elsewhere classified
Abstract

Supplemental material, Reviewer_2_v.1 for Early and sustained symptom improvement with umeclidinium/vilanterol versus monotherapy in COPD: a post hoc analysis of the EMAX randomised controlled trial by Edward M Kerwin, Isabelle H Boucot, Claus F Vogelmeier, Francois Maltais, Ian P Naya, Lee Tombs, Paul W Jones, David A Lipson, Tom Keeley and Leif Bjermer in Therapeutic Advances in Respiratory Disease

Published
2020
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results